Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Other Non-Current Liabilities (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $1.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 91.41% to $1.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.7 million, a 91.41% increase, with the full-year FY2024 number at $2.1 million, up 481.59% from a year prior.
  • Other Non-Current Liabilities was $1.7 million for Q3 2025 at Nuvation Bio, down from $2.4 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.8 million in Q1 2025 to a low of $353000.0 in Q4 2023.
  • A 3-year average of $1.4 million and a median of $1.4 million in 2024 define the central range for Other Non-Current Liabilities.
  • Biggest YoY gain for Other Non-Current Liabilities was 481.59% in 2024; the steepest drop was 48.25% in 2024.
  • Nuvation Bio's Other Non-Current Liabilities stood at $353000.0 in 2023, then skyrocketed by 481.59% to $2.1 million in 2024, then fell by 15.34% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Other Non-Current Liabilities are $1.7 million (Q3 2025), $2.4 million (Q2 2025), and $2.8 million (Q1 2025).